$9.36
+0.21(2.35%)
Mkt Cap $278M
$8.66
$29.60
52-Week Range
At A Glance
1
ClearPoint Neuro, Inc.
2
Revenue is primarily driven by Biologics And Drug Delivery (18.2%) and Product (17.3%).
3
Most recently: of this Form 8-K, as well as Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as ame (2026-01-12).
$278M
Market Cap
$39M
Revenue
-$27M
Net Income
Employees115
Fundamentals
How The Business Makes Money
Revenue by Segment
Biologics And Drug Delivery18.2%($31M)
Product17.3%($29M)
Service15.4%($26M)
Biologics And Drug Delivery Services And License Fees13.7%($23M)
Neurosurgery Navigation And Therapy11.1%($19M)
Neurosurgery Navigation And Therapy-Disposable Products10.5%($18M)
Biologics And Drug Delivery Disposable Products4.6%($8M)
Capital Equipment And Software3.3%($6M)
Capital Equipment And Software Systems And Software Products2.1%($4M)
Capital Equipment Related Service Revenue2%($3M)
Capital Equipment And Software Services1.2%($2M)
Neurosurgery Navigation And Therapy-Services0.5%($931.0K)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001285550
ISINUS18507C1036
CUSIP18507C103
Phone888 287 9109
Address120 S. Sierra Avenue, Solana Beach, CA, 92075, US
SEC EDGAR